Roivant Sciences Ltd (ROIV)

Exchange
NASDAQ
Symbol
ROIV
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
None
Country
USA

Stock price

At close: November 5, 2024

  • Open
    11.50
  • High
    11.67
  • Low
    11.40
  • Close
    11.66
  • Volume
    2,531,620

Financial ratios

Mar 31, 2024

Activity ratios
Inventory turnover
19.50
Receivables turnover
1.68
Payables turnover
12.92
Working capital turnover
0.01
Days of inventory on hand (DOH)
18.72
Days of sales outstanding (DSO)
217.11
Number of days of payables
28.26
Fixed asset turnover
4.72
Total asset turnover
0.01
 Liquidity ratios
Current ratio
25.24
Quick ratio
24.70
Cash ratio
24.50
Cash conversion cycle
207.57
 Solvency ratios
Debt-to-assets ratio
0.03
Debt-to-capital ratio
0.03
Debt-to-equity ratio
0.03
Financial leverage ratio
1.21
Interest coverage
126.69
 Profitability ratios
Gross profit margin
-663.68%
Operating profit margin
4,712.46%
Pretax margin
4,855.92%
Net profit margin
4,831.22%
Operating return on assets (Operating ROA)
58.73%
Return on assets (ROA)
60.21%
Return on total capital
71.37%
Return on equity (ROE)
72.86%